Pilot Study of Fosamax in Spinal Cord Injury

Summary

Study is designed to evaluate the efficacy of oral fosamax in prevention on osteoporosis in acute spinal cord injury. Efficacy will be measured by a duel energy X-Ray absorptiometry (DEXA) scan every 6 months. Patients will complete 3 visits, screening, 6 months, 12 months and be required to take oral fosamax versus placebo weekly.

Timeline

Start

2010-06

Primary completion

2012-12

Completion

2012-12

Drugs

Indications